AskBio Inc.

About AskBio Inc.

AskBio Inc. is a pioneering biotechnology company based in the UK, dedicated to advancing gene therapies for a range of genetic disorders. With a strong commitment to innovation, AskBio focuses on developing cutting-edge solutions that harness the power of gene editing and delivery systems.

The company’s core mission is to transform the lives of patients suffering from rare and debilitating diseases through its proprietary technologies. AskBio’s research and development efforts are centred around creating safe and effective gene therapies that can provide long-lasting benefits.

One of the key strengths of AskBio is its robust pipeline of product candidates, which are designed to address unmet medical needs. The company collaborates with leading academic institutions and industry partners to accelerate the development of its therapies.

AskBio is also committed to maintaining the highest standards of quality and compliance in its operations. The company adheres to rigorous regulatory guidelines to ensure that its products meet the necessary safety and efficacy requirements.

In addition to its focus on therapeutic development, AskBio actively engages in community outreach and education initiatives to raise awareness about genetic disorders and the potential of gene therapy.

With a team of experienced professionals and a culture of collaboration, AskBio Inc. is poised to make significant contributions to the field of biotechnology and improve patient outcomes globally.

• Founded: 2018
• Headquarters: United Kingdom
• Employee Count: 50-100